Feld Michael 4

What Happened
Michael Feld, EVP, Chief Revenue Officer and President, Life Sciences at Becton Dickinson & Co., sold 75 shares on 2026-01-26 at $202.73 per share, generating proceeds of approximately $15,205. This was a sale (not a purchase), and the transaction size was modest relative to typical executive holdings.

Key Details

• Transaction date and price: 2026-01-26 — 75 shares at $202.73 per share.
• Total proceeds: ~$15,205.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Plan/footnote: Reported as made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2025.
• Filing date: Form 4 filed 2026-01-28; no indication in the excerpt that the filing was late.
• Transaction code: S = Sale.

Context
Sales executed under a 10b5-1 plan are pre-arranged and often routine, so they do not necessarily reflect the insider’s current view of the company. For retail investors, purchases are generally more informative about insider sentiment; this small, pre-planned sale should be viewed accordingly.